Analytical Data
-
Gene name
CEACAM6
- Application
-
Alternative Names
CEACAM6；NCA；Carcinoembryonic antigen-related cell adhesion molecule 6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P40199
-
Expression Region
35-320aa
-
AA Sequence
KLTIESTPFN VAEGKEVLLL AHNLPQNRIG YSWYKGERVD GNSLIVGYVI GTQQATPGPA YSGRETIYPN ASLLIQNVTQ NDTGFYTLQV IKSDLVNEEA TGQFHVYPEL PKPSISSNNS NPVEDKDAVA FTCEPEVQNT TYLWWVNGQS LPVSPRLQLS NGNMTLTLLS VKRNDAGSYE CEIQNPASAN RSDPVTLNVL YGPDGPTISP SKANYRPGEN LNLSCHAASN PPAQYSWFIN GTFQQSTQEL FIPNITVNNS GSYMCQAHNS ATGLNRTTVT MITVSG
-
Molecular Weight
32 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6) is a member of the CEACAM family and has been shown to play a significant role in various biological processes, including cell adhesion, immune response modulation, and tumor progression. Due to its overexpression in several malignancies, especially colorectal cancer, CEACAM6 has emerged as an important biomarker for cancer diagnosis and prognosis. Researchers have been investigating CEACAM6 for its potential as a therapeutic target, exploring its involvement in tumor cell proliferation, migration, and immune evasion. The development of recombinant CEACAM6 proteins has facilitated detailed studies of its structure and function, enabling the identification of key interactions with other cellular components. Furthermore, the generation of specific antibodies against CEACAM6 has opened pathways for targeted therapies and diagnostic applications. Overall, the research surrounding CEACAM6 not only contributes to our understanding of cancer biology but also holds promise for the development of innovative strategies in cancer treatment and detection.
